True North Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-12,878
| Closed | -$458K | – | 221 |
|
|
2023
Q1 | $458K | Sell |
12,878
-5,174
| -29% | -$184K | 0.13% | 132 |
|
|
2022
Q4 | $634K | Hold |
18,052
| – | – | 0.22% | 99 |
|
|
2022
Q3 | $531K | Buy |
+18,052
| New | +$531K | 0.17% | 109 |
|
|
2022
Q2 | – | Sell |
-18,070
| Closed | -$983K | – | 202 |
|
|
2022
Q1 | $983K | Sell |
18,070
-152
| -0.8% | -$8.27K | 0.26% | 83 |
|
|
2021
Q4 | $1M | Hold |
18,222
| – | – | 0.17% | 113 |
|
|
2021
Q3 | $870K | Sell |
18,222
-36
| -0.2% | -$1.72K | 0.17% | 113 |
|
|
2021
Q2 | $908K | Sell |
18,258
-4
| -0% | -$199 | 0.19% | 102 |
|
|
2021
Q1 | $814K | Sell |
18,262
-298
| -2% | -$13.3K | 0.19% | 97 |
|
|
2020
Q4 | $853K | Sell |
18,560
-3,568
| -16% | -$164K | 0.22% | 87 |
|
|
2020
Q3 | $1.04M | Buy |
22,128
+332
| +2% | +$15.6K | 0.3% | 71 |
|
|
2020
Q2 | $1.11M | Buy |
21,796
+15,551
| +249% | +$793K | 0.27% | 74 |
|
|
2020
Q1 | $295K | Buy |
6,245
+91
| +1% | +$4.3K | 0.1% | 99 |
|
|
2019
Q4 | $361K | Buy |
+6,154
| New | +$361K | 0.1% | 78 |
|